Among recipients of subcutaneous implantable cardioverter defibrillators, the omission of defibrillation testing (DT) was not associated with significant differences in mortality, or in the rates of ...
People getting a subcutaneous implantable cardioverter-defibrillator (S-ICD) did fine skipping the defibrillation test after all, according to the PRAETORIAN-DFT randomized trial. In people randomized ...
For patients getting a subcutaneous implantable cardioverter-defibrillator (S-ICD), routine defibrillation testing could be safely skipped when using a scoring system to evaluate device position and ...
The extravascular implantable cardioverter–defibrillator (ICD) has a single lead implanted substernally to enable pause-prevention pacing, antitachycardia pacing, and defibrillation energy similar to ...
Defibrillation testing of implantable cardioverter–defibrillators (ICDs) does not improve outcomes compared with device implantation without testing and, therefore, “defibrillation testing during ...
Please provide your email address to receive an email when new articles are posted on . SAN FRANCISCO — Routine defibrillation testing appears to be safe, but does not improve outcomes in patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results